Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-544 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18634 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04 |
filingDate |
2001-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b3cd32e23ba532ec099c9726b12d99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9373b799beccdfcf1c25dc6e2f89a84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ea6d561a7fc2ae636b89ba362fb1991 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b40dfc3ad2097754a6fabcb011c67c22 |
publicationDate |
2003-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003082209-A1 |
titleOfInvention |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
abstract |
Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an anti-PIV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete human or bovine PIV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different PIV. Chimeric human-bovine PIV of the invention include a partial or complete “background” PIV genome or antigenome derived from or patterned after a human or bovine PIV virus combined with one or more heterologous gene(s) or genome segment(s) of a different PIV virus to form the human-bovine chimeric PIV genome or antigenome. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009263883-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113322241-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7632508-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005048030-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011189232-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9034343-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006099226-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013052718-A1 |
priorityDate |
2000-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |